Dziadziuszko R, Peters S, Mok T, Camidge DR, et al. Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK+ Non-small Cell Lung Cancer in the Global Phase III ALEX Trial. Clin Cancer Res 2022 Mar 11. pii: 681795. doi: 10.1158/1078-0432.CCR-21-2840.
PMID: 35275991